Suchergebnisse - "Davis, Audrey"

PubPharm (74)

1

Organophosphate toxicity patterns : A new approach for assessing organophosphate neurotoxicity

enthalten in: Journal of hazardous materials | 2024

von Karaboga, S. | Severac, F. | Collins, E. | +4

2

The optimization of poly(vinyl)-alcohol-alginate beads with a slow-release compound for the aerobic cometabolism of chlorinated aliphatic hydrocarbons

enthalten in: RSC sustainability | 2024

von Harris, C. | Gedde, H. | Davis, A. | +3

3

Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents

enthalten in: Molecules (Basel, Switzerland) | 2024

von Antonijevic, M. | Charou, D. | Davis, A. | +9

4

Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation

enthalten in: Molecules (Basel, Switzerland) | 2022

von Malek, R. | Simakov, A. | Davis, A. | +10

5

Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment

enthalten in: Pharmaceutics | 2021

von Séguy, L. | Guyon, L. | Maurel, M. | +7

6

Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease

enthalten in: British journal of clinical pharmacology | 2021

von Chrétien, B. | Jourdan, J. | Davis, A. | +8

7

Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer's Disease Treatment through Rigidification Strategy

enthalten in: Molecules (Basel, Switzerland) | 2021

von Lecoutey, C. | Legay, R. | Davis, A. | +3

8

Pleiotropic prodrugs : Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease

enthalten in: European journal of medicinal chemistry | 2021

von Toublet, F. | Lalut, J. | Hatat, B. | +10

9

Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease

enthalten in: British Journal of Clinical Pharmacology | 2021

von Chrétien, B. | Jourdan, J. | Davis, A. | +8

10

First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer's Disease

enthalten in: Molecules (Basel, Switzerland) | 2020

von Guieu, B. | Lecoutey, C. | Legay, R. | +6

1
2
3
4
5
6
7
8
Nächster »
[8]